ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE

Ibokhimov Dilshod Dilmurod ogli; Urolov Zhavlonbek Yuzbay ogli; Omonkulova Shokhsanam Otajon qizi; Khabibullaev Fayoziddin Tolibjon ogli; Kasimov Arslanbek Atabaevich

ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE

Authors

Ibokhimov Dilshod Dilmurod ogli Clinical Resident, Department of Neurology Samarkand State Medical University
Urolov Zhavlonbek Yuzbay ogli Clinical Resident, Department of Neurology Samarkand State Medical University
Omonkulova Shokhsanam Otajon qizi Clinical Resident, Department of Neurology Samarkand State Medical University
Khabibullaev Fayoziddin Tolibjon ogli Clinical Resident, Department of Neurology Samarkand State Medical University
Kasimov Arslanbek Atabaevich PhD, Associate Professor, Department of Neurology Samarkand State Medical University

Keywords:

antiplatelet agents, antiplatelet therapy, secondary prevention

Abstract

This literature review presents current concepts of antiplatelet therapy as an important component of secondary prevention of ischemic stroke. Based on evidence-based medicine data, characteristics of antiplatelet agents included in clinical guidelines and standards for treating patients with ischemic stroke are presented. The main principles of selection and tactics for prescribing antiplatelet drugs to patients with ischemic stroke at different stages of the disease are provided.

Downloads

View Article

Published

2025-06-12

How to Cite

Dilmurod ogli, I. D., Yuzbay ogli, U. Z., Otajon qizi, O. S., Tolibjon ogli, K. F., & Atabaevich, K. A. (2025). ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE. International Journal of Cognitive Neuroscience and Psychology, 3(6), 18–22. Retrieved from https://medicaljournals.eu/index.php/IJCNP/article/view/1904